PA-8 Catalog No.:M27505-C InChi: InChI=1S/C19H18N2O4S/c1-12(22)14-4-5-15(20-11-14)8-9-25-16-6-2-13(3-7-16)10-17-18(23)21-19(24)26-17/h2-7

InChi: InChI=1S/C19H18N2O4S/c1-12(22)14-4-5-15(20-11-14)8-9-25-16-6-2-13(3-7-16)10-17-18(23)21-19(24)26-17/h2-7

InChi: InChI=1S/C27H35F2N7O3/c1-34-12-10-18(11-13-34)31-24(37)17-8-9-20(22(14-17)39-3)32-26-30-15-21-23(33-26)36(19-6-4-5-7-19)16-27(28

Cetrorelix diacetate has comparable antiproliferative effects as GnRH-I agonists indicating that the dichotomy of GnRH-I agonists and antagonists might not apply to the GnRH-I system in cancer cells[2]

InChiKey: KGNGTSCIQCLKEH-SYCVNHKBSA-N

Chemical Name: 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-{[4-(pyrazin-2-yl)pyrimidin-2-yl]amino}benzamide

PA-8 Catalog No.:M27505-C InChi: InChI=1S/C19H18N2O4S/c1-12(22)14-4-5-15(20-11-14)8-9-25-16-6-2-13(3-7-16)10-17-18(23)21-19(24)26-17/h2-7PA 8 is a potent, selective and orally active PACAP type I (PAC1) receptor antagonist. PA 8 inhibits the phosphorylation of CREB induced by PACAP in PAC1 , but not VPAC1 or VPAC2 receptor. PA 8 also inhibits PACAP induced cAMP elevation with an IC50 of 2 nM. Product information CAS Number: 878437 15 1 Molecular Weight: 342. 35 Formula: C17H18N4O4 Chemical Name: 2 amino 5 [3 methoxy 4 (prop 2 en 1 yloxy)phenyl] 3H,4H,5H,6H,7H,8H pyrido[2,3 d]pyrimidine